Search

Your search keyword '"A. van Tienhoven"' showing total 19 results

Search Constraints

Start Over You searched for: Author "A. van Tienhoven" Remove constraint Author: "A. van Tienhoven" Journal hpb Remove constraint Journal: hpb
19 results on '"A. van Tienhoven"'

Search Results

1. Diagnostic performance of endoscopic tissue acquisition for pancreatic ductal adenocarcinoma in the PREOPANC and PREOPANC-2 trials

2. Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit

3. Preoperative Radiotherapy on the Transection Margin in Patients at High Risk of Pancreatic Fistula after Pancreatoduodenectomy (FIBROPANC): A Multicenter Phase II Study

5. Improved Overall Survival in Pancreatic Cancer with Preoperative Chemoradiotherapy: Long-term Results of the PREOPANC Trial

8. Surgical Complications after Preoperative Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Cancer in a Multicentre, Randomised Controlled Clinical Trial (PREOPANC-1)

9. Surgical Complications after Preoperative Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Cancer in a Multicentre, Randomised Controlled Clinical Trial (PREOPANC-1)

10. Neoadjuvant FOLFIRINOX versus Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Cancer: Update on the Nationwide Multicenter PREOPANC-2 Randomized Trial

11. Improved Overall Survival in Pancreatic Cancer with Preoperative Chemoradiotherapy: Long-term Results of the PREOPANC Trial

12. High-dose stereotactic body radiotherapy by real-time MRI guided tracking for locally advanced or recurrent pancreatic cancer: prospective single-center study

13. Preoperative chemoradiotherapy diminishes the risk of postoperative pancreatic fistula after pancreatoduodenectomy

14. Nationwide trends in incidence, treatment and survival of patients with pancreatic cancer in the past two decades

16. Nationwide trends in incidence, treatment and survival of patients with pancreatic cancer in the past two decades

17. Neoadjuvant FOLFIRINOX versus neoadjuvant chemoradiotherapy and adjuvant chemotherapy for (borderline) resectable pancreatic cancer: Update on the PREOPANC-2 study

18. Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit

19. Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy for borderline resectable and resectable pancreatic cancer (PREOPANC-2): a multicenter randomized controlled trial.

Catalog

Books, media, physical & digital resources